about
Transcriptomic Study on Ovine Immune Responses to Fasciola hepatica InfectionFascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanideFasciolosis in South America: epidemiology and control challenges.Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family.Characterisation of two calmodulin-like proteins from the liver fluke, Fasciola hepatica.Induction of immunity in sheep to Fasciola hepatica with mimotopes of cathepsin L selected from a phage display library.Population dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands.Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica.Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom.Recent advances in candidate-gene and whole-genome approaches to the discovery of anthelmintic resistance markers and the description of drug/receptor interactions.Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.Screening anthelmintic resistance to triclabendazole in Fasciola hepatica isolated from sheep by means of an egg hatch assay.Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field CasesFasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.Triclabendazole for the treatment of fascioliasis and paragonimiasis.A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.A major cathepsin B protease from the liver fluke Fasciola hepatica has atypical active site features and a potential role in the digestive tract of newly excysted juvenile parasitesIn vitro tegumental alterations on adult Fasciola gigantica caused by mefloquine.Anthelmintics Resistance; How to Overcome it?Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.Juvenile-specific cathepsin proteases in Fasciola spp.: their characteristics and vaccine efficacies.Fasciola hepatica demonstrates high levels of genetic diversity, a lack of population structure and high gene flow: possible implications for drug resistance.Development of Fasciola Vaccine in an Animal Model.Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.Fasciola hepatica - the pilot study of in vitro assessing immune response against native and recombinant antigens of the fluke.Molecular cloning and characterization of a glutathione S-transferase in the tropical liver fluke, Fasciola gigantica.In vitro ovicidal activity of Peganum harmala seeds extract on the eggs of Fasciola hepatica.Network Analysis of the Systemic Response to Fasciola hepatica Infection in Sheep Reveals Changes in Fibrosis, Apoptosis, Toll-Like Receptors 3/4, and B Cell Function.Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheepFasciola and fasciolosis in ruminants in Europe: Identifying research needs.Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle.Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepaticaElectron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.Evaluation of local immune response to Fasciola hepatica experimental infection in the liver and hepatic lymph nodes of goats immunized with Sm14 vaccine antigen.Dairy heifers naturally exposed to Fasciola hepatica develop a type-2 immune response and concomitant suppression of leukocyte proliferation.FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.A Scandinavian case of domestically acquired human fascioliasis.Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.Approach to molecular characterization of different strains of Fasciola hepatica using random amplified polymorphic DNA polymerase chain reaction.Evaluation of a copro-antigen ELISA to detect Fasciola hepatica infection in sheep, cattle and horses.
P2860
Q27303435-101162CF-4B68-4A38-8E8E-8ED9B44235BAQ28535341-39F26897-0F19-48A4-AED3-062CE09D42EBQ30245533-FCE0EDDF-08BC-454F-95DB-FC13A6D7DABDQ33251445-5337123B-5492-4648-933A-96F42F0D53F9Q33286931-58B6116E-AADB-40DA-B94D-36C1A3EAD84EQ33371412-D954BDE7-683E-4660-88BE-55BFCAFA7385Q33676277-949C397F-DE18-4BFC-A583-05F5D3369A0EQ34141229-C476129C-C5D7-48D8-AA34-DD03605E1907Q34627791-12CF6729-9725-4A83-BCA4-0C412668AE4BQ34705912-14082236-7BD4-456F-85F6-6D828BD34A07Q35678778-1E6F9975-C4F4-4B15-AB12-3CA7121429CDQ35757853-B9375192-DF20-4668-A99A-16763EDC7BAFQ36096359-16273811-0983-4BC9-977C-CCDF968223ABQ36184307-C8F8E165-1510-47B3-BC1D-3716AC8955C7Q36322074-000ACFBE-BF82-4186-9724-18B0F0381601Q36386873-29F195EC-3ADC-46B8-B901-715B21E9E3FEQ36444217-29076208-DE47-4B70-AD01-0E556B641760Q36750810-265DA6C1-D7E9-4C7A-BF24-7B7AAA6C5751Q36847608-B93D25C5-E8A5-414E-B667-043BE1D97B28Q38408628-60AC1D54-1F0C-4AB8-A8A0-9A5D2AE24C49Q38534374-AF6FFB1E-62EB-4789-9B29-9CC39C659E5BQ38784552-035AEC49-FCFC-48CA-A539-DE984AA411E9Q38881498-0056071D-FA1C-432D-A772-DEC99EE315A7Q38958762-E7953012-F721-4670-8D3A-F0BBC2B812F1Q39043252-1483B9FD-B7C8-48BB-B960-0B1566A6AC7EQ39103026-B44E246E-A705-452B-8541-C256AEF36FF0Q40171999-E10B4070-9E6D-42B9-9006-8AF435ED299FQ40219501-89D8E8EE-96A0-46A6-8ECD-1981EA63F5E3Q41436763-0716AFD5-A22F-4A9B-8107-389ADC21937CQ41922974-50A3F7A9-77CF-4DCB-ACF5-041685017939Q41991869-C9B4814D-A506-4180-B32E-2D0B7DF102FBQ42026984-027AD03E-D99C-4877-BD35-923AC4063FF6Q42458074-401B5D46-2CAF-4454-8FC3-A8CFDA238FA7Q42909596-FF240F7D-855E-4F44-A335-61E687336BCEQ43168328-CCF9E9A7-1161-4568-8C65-0542A6B38C85Q43458659-76F5CFC3-80EF-42E4-8722-C0CF50969BEAQ44114333-4660D2B6-D8D6-46F7-946B-49AC247D5F2FQ46050142-67CA695E-D744-430C-9CDF-32235F3E487DQ46785681-40AD0F67-4F56-4191-9C02-6B775C549900Q46847742-AED5F392-7560-4A3E-8C1B-96F062B538DB
P2860
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Resistance of Fasciola hepatica to triclabendazole.
@ast
Resistance of Fasciola hepatica to triclabendazole.
@en
Resistance of Fasciola hepatica to triclabendazole.
@nl
type
label
Resistance of Fasciola hepatica to triclabendazole.
@ast
Resistance of Fasciola hepatica to triclabendazole.
@en
Resistance of Fasciola hepatica to triclabendazole.
@nl
prefLabel
Resistance of Fasciola hepatica to triclabendazole.
@ast
Resistance of Fasciola hepatica to triclabendazole.
@en
Resistance of Fasciola hepatica to triclabendazole.
@nl
P1476
Resistance of Fasciola hepatica to triclabendazole.
@en
P2093
P304
P356
10.1111/J.1751-0813.1995.TB03546.X
P577
1995-07-01T00:00:00Z